SGX:CLI News 17 December 2025

CapitaLand Investment stock jumps near 52-week high as Feb 11 results loom

CapitaLand Investment shares rose 1% to S$3.11 in afternoon trading Tuesday, near a 52-week high, ahead of full-year results due Feb. 11. CapitaLand India Trust reported a 22% year-on-year increase in distribution per unit to 3.90 Singapore cents, with payment set for March 19. Investors are watching upcoming fund earnings for signals on rents and valuations.

3 February 2026

Earnings Reports·SGX:CLI·Stock Market

CapitaLand Investment stock price ticks up near 52-week high as investors parse filings and eye Feb 11 results

CapitaLand Investment granted 317,809 share awards to non-executive directors, valued at S$957,157.70 and settled using treasury shares, according to an SGX filing. Shares edged up 0.3% to S$3.09, near a 52-week high, on volume of 7.76 million. Investors await the company’s full-year earnings on Feb. 11 amid recent gains in its Malaysia and Ascott Trust units.

30 January 2026

Earnings Reports·Real Estate·SGX:CLI·Stock Market

CapitaLand Investment stock price rallies into weekend as STI hits record; Feb 11 results in focus

CapitaLand Investment shares rose 1.7% to S$3.05 Friday, extending a two-day rally on volume of 16.6 million shares. The Straits Times Index closed at a record 4,891.45, up 1.3%. CapitaLand Investment will release full-year results on Feb. 11 and brief analysts that morning, according to SGX filings.

24 January 2026

SGX:CLI·Stock Market

CapitaLand Investment stock jumps again on SGX as rate bets lift property names into results season

CapitaLand Investment shares rose 1.7% to S$3.05 in Singapore Friday afternoon, near recent highs, as investors returned to property stocks ahead of earnings season. The company will report results on Feb. 11. Trading volumes increased, but no new company updates were released. Market watchers expect Singapore REITs to benefit if interest rates fall.

23 January 2026

Real Estate·SGX:CLI

CapitaLand Investment share price edges up on SGX as Gulf push and Feb results near

CapitaLand Investment shares rose 0.34% to S$2.97 in Singapore on Tuesday, outperforming the Straits Times Index, which slipped 0.05%. Trading followed news of the group’s expansion in logistics and hospitality in the Gulf. Around 10.1 million shares changed hands by mid-afternoon. Investors await the company’s full-year results, due Feb 11.

20 January 2026

SGX:CLI·Stock Market

CapitaLand Investment stock flat as India data centre fund raise sharpens focus on Feb. 11 results

CapitaLand Investment shares traded at S$2.93 Wednesday after the company raised about S$150 million in the first close of its India data centre fund. CLI plans to acquire a 20.2% stake in three Indian data centres for S$99.73 million. Investors await the firm’s FY2025 results on Feb. 11.

14 January 2026

Real Estate·SGX:CLI·Stock Market

CapitaLand Investment stock rises to S$2.89 as logistics push sharpens focus on Feb 11 results

CapitaLand Investment shares rose 1.8% to S$2.89 Friday after it disclosed a minority stake in Ally Logistic Property and plans for a S$260 million automated warehouse in Singapore. The facility, set for completion in 2028, is fully leased to ALP under a master lease. Full-year 2025 results are due Feb. 11. Trading volume reached about 20.4 million shares.

11 January 2026

Earnings Reports·Real Estate·SGX:CLI·Stock Market

CapitaLand Investment stock climbs after S$260 million Singapore automated logistics bet

CapitaLand Investment shares rose 2.16% to S$2.84 in Singapore after announcing a S$260 million automated logistics facility in Jurong and a minority stake in Ally Logistic Property. The five-storey warehouse, due in 2028, will be fully leased to ALP. Mitsui O.S.K. Lines is also investing through the logistics fund. Investors await February results for updates on fee growth and fundraising.

8 January 2026

Real Estate·SGX:ALP·SGX:CLI·Stock Market

Singapore Stock Market Today (Dec 17, 2025): STI Slips as Global Rate Jitters Offset Strong Exports; Suntec REIT, Keppel DC REIT and CapitaLand-UOL in Focus

SINGAPORE, Dec 17, 2025 — Singapore shares were softer on Wednesday, with the benchmark Straits Times Index (STI) easing as investors balanced upbeat domestic data against a cautious global backdrop shaped by shifting interest-rate expectations, oil’s rebound, and a busy central-bank calendar. The STI was last hovering around 4,566, after opening at 4,555.67 and trading in a 4,545.77–4,575.13 range, with volume reported at about 88.4 million. Investing.com The muted tone came even as Singapore posted a stronger-than-expected jump in November exports and economists upgraded GDP expectations in the latest Monetary Authority of Singapore (MAS) survey — data that would typically

17 December 2025

SGX:AJBU·SGX:CLI·SGX:T82·SGX:UOL·Stock Market

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

7 February 2026

Novartis shares closed up 0.6% in Zurich at 119.96 francs Friday, with U.S. ADRs gaining 1.5%. The company broke ground on a new San Diego research center and reported a positive draft reimbursement recommendation for Kisqali in Canada. Investors are watching for the March 6 annual meeting and March 10 ex-dividend date tied to a proposed 3.70-franc payout.

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026

AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

7 February 2026

Wells Fargo shares rose 2.63% to $93.97 Friday as U.S. stocks rebounded. The stock traded ex-dividend for a $0.45 payout due March 1. Investors await delayed U.S. jobs and inflation data next week and a scheduled CFO appearance at a bank conference.

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface

7 February 2026

Merck shares closed up 1.8% at $121.93 Friday after Health Canada approved its ENFLONSIA RSV antibody for infants. Guggenheim raised its price target to $140. Insider filings showed three executives sold shares this week. Merck’s stock ended just below its 52-week high, with about 13 million shares traded.

SGX:CLI News 17 December 2025 - 3 February 2026

Stock Market Today